Iambic Therapeutics, a Phase 1 biotech using its AI platform to develop small molecule cancer therapies, raised $150 million ...

Amaero, a producer of titanium and refractory metal powders for defense and aerospace 3D printing, raised $20 million in its ...

Tungsten prices have soared over the past two years amid supply constraints, spurring miners to tap public markets.

EuroSPAC Acquisition, a blank check company led by the CEO of shipping company Euroseas targeting the industrials sector, ...

Hall Chadwick Acquisition II, a blank check company targeting critical materials, infrastructure, and defense, lowered the ...

City Therapeutics, a Phase 1 biotech developing RNA interference therapies for thromboembolic diseases, announced terms for ...

Two biotechs priced IPOs this past week and more joined the pipeline, along with a billion-dollar data center developer, an emerging markets fintech, and a dental treatment company.Autoimmune biotech ...

Latest Listings: Africa-focused fintech Airtel Africa ($700mm) completed London's largest IPO since 2021, but broke issue on ...

FireFly Robotics, which makes robotic turfgrass harvesters and autonomous golf course mowers, filed on Wednesday with the SEC ...

No IPOs are currently scheduled for the week ahead, signaling a quiet start to the fourth quarter.A few companies are eligible to launch in the coming week, including neocloud firm Nscale (NSCL).

Iambic Therapeutics, a Phase 1 biotech using its AI platform to develop small molecule cancer therapies, announced terms for ...

Retension Pharmaceuticals, a Phase 2b biotech developing an in-licensed treatment for hypertension, raised $45 million by ...